Author

A. L. Wolf

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:proteomics· 1

Frequent Co-Authors

A. M. Acanda de la Rocha· 1 shared J. W. Chambers· 1 shared M. Rodriguez-Silva· 1 shared W. C. Reinhold· 1 shared W. Wang· 1 shared Y. Lai· 1 shared Y. Liu· 1 shared Y. Pommier· 1 shared

Activity by Year

2019-2019 · peak 1/yr

Co-Author Collaboration Network

9 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. M. Acanda de la Rocha

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Tyrosyl-DNA phosphodiesterase 1 and topoisomerase I activities as predictive indicators for Glioblastoma susceptibility to genotoxic agents

W. Wang, M. Rodriguez-Silva, A. M. Acanda de la Rocha, A. L. Wolf, Y. Lai, Y. Liu, W. C. Reinhold, Y. Pommier, J. W. Chambers, Y.-C. Tse-Dinh

This study identifies the TDP1/TOP1 activity ratio as a predictive indicator for GBM susceptibility to irinotecan, suggesting TDP1 inhibition could enhance treatment efficacy.

bioRxiv · Jul 14, 2019Cancer Biology